Ocular Hypertension Completed Phase 3 Trials for Timolol (DB00373)

Also known as: Intraocular pressure raised / Ocular Hypertension (OHT) / Hypertension Ocular / Hypertension, Ocular / Intraocular pressure high / Intraocular hypertension / Ocular Hypertension (OH) / Elevated intraoccular pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02565173Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle GlaucomaTreatment
NCT01749930Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00856622A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In PatientsTreatment
NCT01254604Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)Treatment
NCT03257813Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)Treatment
NCT02278614Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous PatientsTreatment
NCT00800267A Study of Glaucoma or Ocular Hypertension in Patients Within the United StatesTreatment
NCT00652106Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionTreatment
NCT00576342Patient Preference StudyTreatment
NCT00546286A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)Treatment
NCT01026831Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)Treatment
NCT01217606Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00760539Safety and Efficacy of Travoprost/Timolol BAC-freeTreatment
NCT00751049A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United KingdomTreatment
NCT00751127A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular HypertensionTreatment
NCT00751062A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within ScandinaviaTreatment
NCT01241240Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01306461Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant AdministrationsTreatment
NCT01292460Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against MonotherapiesTreatment
NCT01342094DE-111 Against Timolol Ophthalmic Solution 0.5%Treatment
NCT01357616Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01749904Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00651612Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension PatientsTreatment
NCT00672997A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00108017Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)Treatment
NCT00465803A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular HypertensionTreatment
NCT00314158A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00314171A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00311389A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00293787A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00293800A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00277498A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaTreatment
NCT00219596Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular HypertensionTreatment
NCT00230763Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular PressureTreatment
NCT00150267A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular HypertensionTreatment
NCT00159653A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaTreatment
NCT00383019A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).Treatment
NCT00333125A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment